Tag Archives: Cardiovascular risk

Novo Nordisk’s SELECT Trial Shows Semaglutide 2.4 mg Cuts Cardiovascular Risk in Overweight and Obese Adults

(IN BRIEF) Novo Nordisk, a global healthcare company, has reported the headline findings from the SELECT cardiovascular outcomes trial. This double-blinded study assessed the impact of subcutaneous once-weekly semaglutide 2.4 mg in comparison to placebo as an adjunct to standard … Read the full press release

European Commission funded project YOUNG 50 aimed at preventing cardiovascular disease risk factors in people aged 50 launches in Luxembourg, Lithuania and Romania

(PRESS RELEASE) LUXEMBOURG, 29-Nov-2021 — /EuropaWire/ — Luxembourg Institute of Health (LIH), a public biomedical research organisation, has announced that a project called YOUNG 50 and funded by the European Commission launches in Luxembourg with the aim to screen and … Read the full press release

European Society of Cardiology, Prof Scott Montgomery: Severe infections in adulthood are associated with a contemporaneously raised risk of cardiovascular disease

SOPHIA ANTIPOLIS, 07-Aug-2017 — /EuropaWire/ — Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year, according to research published today in the European Journal of Preventive … Read the full press release